Stryker Net Profit Margin 2010-2024 | SYK
Current and historical net profit margin for Stryker (SYK) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Stryker net profit margin for the three months ending December 31, 2024 was .
| Stryker Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $22.60B | $2.99B | 13.25% |
| 2024-09-30 | $21.97B | $3.59B | 16.34% |
| 2024-06-30 | $21.39B | $3.45B | 16.12% |
| 2024-03-31 | $20.96B | $3.36B | 16.03% |
| 2023-12-31 | $20.50B | $3.17B | 15.44% |
| 2023-09-30 | $19.89B | $2.59B | 13.00% |
| 2023-06-30 | $19.46B | $2.71B | 13.92% |
| 2023-03-31 | $18.95B | $2.63B | 13.86% |
| 2022-12-31 | $18.45B | $2.36B | 12.78% |
| 2022-09-30 | $17.95B | $2.46B | 13.69% |
| 2022-06-30 | $17.63B | $2.08B | 11.79% |
| 2022-03-31 | $17.43B | $2.02B | 11.56% |
| 2021-12-31 | $17.11B | $1.99B | 11.66% |
| 2021-09-30 | $16.67B | $1.90B | 11.40% |
| 2021-06-30 | $16.25B | $2.08B | 12.82% |
| 2021-03-31 | $14.72B | $1.41B | 9.57% |
| 2020-12-31 | $14.35B | $1.60B | 11.14% |
| 2020-09-30 | $14.22B | $1.76B | 12.35% |
| 2020-06-30 | $14.07B | $1.60B | 11.38% |
| 2020-03-31 | $14.96B | $2.16B | 14.47% |
| 2019-12-31 | $14.88B | $2.08B | 13.99% |
| 2019-09-30 | $14.55B | $3.43B | 23.55% |
| 2019-06-30 | $14.20B | $3.55B | 24.99% |
| 2019-03-31 | $13.88B | $3.52B | 25.38% |
| 2018-12-31 | $13.60B | $3.55B | 26.12% |
| 2018-09-30 | $13.28B | $1.24B | 9.31% |
| 2018-06-30 | $13.04B | $1.08B | 8.28% |
| 2018-03-31 | $12.73B | $1.02B | 8.00% |
| 2017-12-31 | $12.44B | $1.02B | 8.20% |
| 2017-09-30 | $12.13B | $1.78B | 14.67% |
| 2017-06-30 | $11.96B | $1.70B | 14.22% |
| 2017-03-31 | $11.79B | $1.69B | 14.33% |
| 2016-12-31 | $11.33B | $1.65B | 14.54% |
| 2016-09-30 | $10.88B | $1.66B | 15.24% |
| 2016-06-30 | $10.47B | $1.61B | 15.33% |
| 2016-03-31 | $10.06B | $1.62B | 16.07% |
| 2015-12-31 | $9.95B | $1.44B | 14.47% |
| 2015-09-30 | $9.85B | $1.18B | 11.95% |
| 2015-06-30 | $9.82B | $0.93B | 9.50% |
| 2015-03-31 | $9.75B | $0.67B | 6.86% |
| 2014-12-31 | $9.68B | $0.52B | 5.32% |
| 2014-09-30 | $9.53B | $0.64B | 6.73% |
| 2014-06-30 | $9.29B | $0.69B | 7.40% |
| 2014-03-31 | $9.14B | $0.77B | 8.45% |
| 2013-12-31 | $9.02B | $1.01B | 11.15% |
| 2013-09-30 | $8.89B | $0.89B | 10.01% |
| 2013-06-30 | $8.79B | $1.14B | 12.97% |
| 2013-03-31 | $8.69B | $1.25B | 14.41% |
| 2012-12-31 | $8.66B | $1.30B | 14.99% |
| 2012-09-30 | $8.53B | $1.43B | 16.74% |
| 2012-06-30 | $8.51B | $1.40B | 16.48% |
| 2012-03-31 | $8.45B | $1.39B | 16.42% |
| 2011-12-31 | $8.31B | $1.35B | 16.19% |
| 2011-09-30 | $8.09B | $1.24B | 15.32% |
| 2011-06-30 | $7.82B | $1.25B | 15.96% |
| 2011-03-31 | $7.54B | $1.26B | 16.69% |
| 2010-12-31 | $7.32B | $1.27B | 17.39% |
| 2010-09-30 | $7.16B | $1.28B | 17.94% |
| 2010-06-30 | $7.04B | $1.18B | 16.70% |
| 2010-03-31 | $6.92B | $1.15B | 16.59% |
| 2009-12-31 | $6.72B | $1.11B | 16.47% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $142.721B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.763B | 27.35 |
| Boston Scientific (BSX) | United States | $152.152B | 38.10 |
| EssilorLuxottica (ESLOY) | France | $133.556B | 0.00 |
| Medtronic (MDT) | Ireland | $108.708B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.613B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.796B | 26.03 |
| ResMed (RMD) | United States | $34.691B | 26.06 |
| GE HealthCare Technologies (GEHC) | United States | $32.200B | 15.29 |
| Agilent Technologies (A) | United States | $30.677B | 20.26 |
| Terumo (TRUMY) | Japan | $28.397B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.827B | 17.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.388B | 12.88 |
| Insulet (PODD) | United States | $17.717B | 75.76 |
| Baxter (BAX) | United States | $15.988B | 11.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.272B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.145B | 17.57 |
| Bio-Rad Laboratories (BIO) | United States | $6.837B | 23.67 |
| Prestige Consumer Healthcare (PBH) | United States | $4.024B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.362B | 28.64 |
| Haemonetics (HAE) | United States | $3.166B | 14.90 |
| Envista Holdings (NVST) | United States | $2.725B | 22.03 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 18.72 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 46.77 |
| QuidelOrtho (QDEL) | United States | $1.875B | 15.70 |
| AtriCure (ATRC) | United States | $1.480B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.401B | 22.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.235B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.05 |
| BioLife Solutions (BLFS) | United States | $1.145B | 0.00 |
| Neogen (NEOG) | United States | $1.096B | 14.03 |
| InMode (INMD) | Israel | $0.981B | 8.98 |
| Phibro Animal Health (PAHC) | United States | $0.754B | 11.56 |
| Evolus (EOLS) | United States | $0.735B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.713B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.580B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.545B | 4.64 |
| Valneva SE (VALN) | France | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.479B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Surmodics (SRDX) | United States | $0.400B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.343B | 14.86 |
| Verano Holdings (VRNOF) | United States | $0.323B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 25.25 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Canopy Growth (CGC) | Canada | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.252B | 15.10 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| Quanterix (QTRX) | United States | $0.223B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Utah Medical Products (UTMD) | United States | $0.170B | 13.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.00 |
| Organigram Global (OGI) | Canada | $0.146B | 0.00 |
| Jin Medical (ZJYL) | China | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Agape ATP (ATPC) | $0.115B | 0.00 | |
| Exagen (XGN) | United States | $0.112B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.079B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.039B | 0.00 |
| Safety Shot (SHOT) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 54.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |